PetIQ Inc (PETQ) Insider Will Santana Sells 20,000 Shares

PetIQ Inc (NASDAQ:PETQ) insider Will Santana sold 20,000 shares of the company’s stock in a transaction that occurred on Thursday, May 23rd. The shares were sold at an average price of $28.16, for a total value of $563,200.00. The transaction was disclosed in a document filed with the SEC, which is available through this link.

Will Santana also recently made the following trade(s):

  • On Tuesday, May 7th, Will Santana sold 20,000 shares of PetIQ stock. The shares were sold at an average price of $27.85, for a total value of $557,000.00.
  • On Wednesday, April 24th, Will Santana sold 20,000 shares of PetIQ stock. The shares were sold at an average price of $30.77, for a total value of $615,400.00.
  • On Thursday, April 11th, Will Santana sold 20,000 shares of PetIQ stock. The shares were sold at an average price of $31.06, for a total value of $621,200.00.
  • On Thursday, March 28th, Will Santana sold 20,000 shares of PetIQ stock. The shares were sold at an average price of $30.39, for a total value of $607,800.00.
  • On Thursday, March 7th, Will Santana sold 20,000 shares of PetIQ stock. The shares were sold at an average price of $25.63, for a total value of $512,600.00.
  • On Wednesday, February 27th, Will Santana sold 20,000 shares of PetIQ stock. The shares were sold at an average price of $30.54, for a total value of $610,800.00.

Shares of PETQ opened at $27.62 on Friday. The firm has a market cap of $778.91 million, a P/E ratio of 22.10, a P/E/G ratio of 1.49 and a beta of 2.04. The company has a quick ratio of 1.51, a current ratio of 2.89 and a debt-to-equity ratio of 0.38. PetIQ Inc has a 12 month low of $19.01 and a 12 month high of $43.93.

PetIQ (NASDAQ:PETQ) last issued its quarterly earnings data on Wednesday, May 8th. The company reported $0.27 EPS for the quarter, topping the Zacks’ consensus estimate of $0.08 by $0.19. PetIQ had a return on equity of 9.47% and a net margin of 0.51%. The firm had revenue of $148.44 million during the quarter, compared to the consensus estimate of $139.03 million. On average, equities analysts forecast that PetIQ Inc will post 0.8 earnings per share for the current fiscal year.

Large investors have recently added to or reduced their stakes in the company. JPMorgan Chase & Co. grew its stake in shares of PetIQ by 6,548.3% in the third quarter. JPMorgan Chase & Co. now owns 137,554 shares of the company’s stock worth $5,407,000 after purchasing an additional 135,485 shares in the last quarter. Campbell Newman Asset Management Inc. grew its stake in shares of PetIQ by 3.8% in the first quarter. Campbell Newman Asset Management Inc. now owns 18,080 shares of the company’s stock worth $568,000 after purchasing an additional 658 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in shares of PetIQ by 226.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 95,881 shares of the company’s stock worth $2,250,000 after purchasing an additional 66,498 shares in the last quarter. BCJ Capital Management LLC bought a new position in shares of PetIQ in the fourth quarter worth $235,000. Finally, Portolan Capital Management LLC grew its stake in shares of PetIQ by 51.6% in the fourth quarter. Portolan Capital Management LLC now owns 93,290 shares of the company’s stock worth $2,190,000 after purchasing an additional 31,768 shares in the last quarter. 89.20% of the stock is owned by institutional investors.

PETQ has been the subject of a number of recent research reports. BidaskClub downgraded PetIQ from a “strong-buy” rating to a “buy” rating in a research note on Saturday, March 9th. ValuEngine upgraded PetIQ from a “hold” rating to a “buy” rating in a research note on Wednesday, February 13th. Raymond James lowered their price objective on PetIQ from $42.00 to $39.00 and set an “outperform” rating for the company in a research note on Monday, March 4th. Zacks Investment Research downgraded PetIQ from a “hold” rating to a “strong sell” rating in a research note on Tuesday, March 5th. Finally, Guggenheim initiated coverage on PetIQ in a research note on Thursday. They set a “buy” rating and a $35.00 price objective for the company. One research analyst has rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and an average price target of $40.71.

COPYRIGHT VIOLATION NOTICE: This story was originally reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this story on another publication, it was stolen and republished in violation of United States & international trademark & copyright laws. The correct version of this story can be accessed at https://sportsperspectives.com/2019/05/26/petiq-inc-petq-insider-will-santana-sells-20000-shares.html.

About PetIQ

PetIQ, Inc operates as a pet health and wellness company. It operates through two segments, Products and Services. It manufactures and distributes veterinarian services and veterinarian-grade pet products, including prescription (Rx) medications, over-the-counter (OTC) flea and tick preventatives, and health and wellness products for dogs and cats.

Further Reading: Trading Options- What is a Strangle?

Insider Buying and Selling by Quarter for PetIQ (NASDAQ:PETQ)

Receive News & Ratings for PetIQ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetIQ and related companies with MarketBeat.com's FREE daily email newsletter.